Biologic Therapies for Giant Cell Arteritis
Robert Harrington,* Shamma Ahmad Al Nokhatha,* Richard Conway Department of Rheumatology, St. James’s Hospital, Dublin, Ireland*These authors contributed equally to this workCorrespondence: Richard ConwayDepartment of Rheumatology, St. James’s Hospital, James Street, Dublin 8, Ir...
Enregistré dans:
Auteurs principaux: | Harrington R, Al Nokhatha SA, Conway R |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/22c6799b78d44b8195de3ff95920067f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Presentation and Real-World Management of Giant Cell Arteritis (Artemis Study)
par: Alfred Mahr, et autres
Publié: (2021) -
Isquemia de extremidades inferiores secundaria a arteritis de la arteria temporal
par: Zárate B.,Cristian, et autres
Publié: (2020) -
Giant Cell Arteritis: The Experience of Two Collaborative Referral Centers and an Overview of Disease Pathogenesis and Therapeutic Advancements
par: Dammacco R, et autres
Publié: (2020) -
A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis
par: Hoon E, et autres
Publié: (2019) -
Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and Treatment
par: Idil Esen, et autres
Publié: (2021)